Does digitoxin still have a place in heart failure treatment? Two new studies reevaluate the role of cardiology’s oldest drug.

GPs can start treatment with certain heart failure drugs that previously had to be initiated by a specialist, NICE has said in updated guidance. Sodium-glucose cotransporter-2 (SGLT2) inhibitors and ...

The PARADIGM‐HF (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) trial revealed that a combined angiotensin receptor blocker (ARB, ...

While heart disease has been the leading cause of death in the U.S. for over a century, the past 50 years have seen a ...

Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Novo Nordisk has recently completed a clinical study titled A ...

The pathophysiology of heart failure is complex, but mitochondrial dysfunction is an emerging therapeutic target to improve cardiac function. In this Consensus Statement, insights into the ...

For patients with heart failure, hospital participation in the IMPLEMENT-HF initiative improves adherence to quadruple ...

U.S. heart disease mortality has dropped 66% since 1970, mainly due to fewer ischemic heart disease deaths. However, deaths ...

Shares of Rocket Pharmaceuticals Inc (NASDAQ:RCKT) advanced 2.4% after the company announced that the U.S. Food and Drug ...

Doctors can now detect heart failure by scanning this other body part. The scanner uses technology similar to facial recognition on a patient’s foot. Storm Newton. Wednesday 04 June 2025 08:01 BST.

This cross-journal Collection welcomes submissions focused on unmet needs in heart failure and that will improve our understanding of, or address, ...

There was discussion at ESC whether Kerendia should be used in place of the SGLT2 inhibitors, or in combination, given that all the benefits of the drug were tied to improvements in heart failure ...